Advanced melanoma
Showing 9951 - 9975 of >10,000
Advanced PD-L1 Positive Malignancies Trial in New York (89Zr?DFO?REGN3504)
Terminated
- Advanced PD-L1 Positive Malignancies
-
New York, New York
- +1 more
Feb 7, 2022
Malignant Peripheral Nerve Sheath Tumour (MPNST) Trial in Oslo (Pembrolizumab)
Terminated
- Malignant Peripheral Nerve Sheath Tumour (MPNST)
-
Oslo, NorwayOslo university Hospital
Jun 21, 2021
Nasopharyngeal Carcinoma Trial in China (SIB-IMRT, Cisplatin)
Unknown status
- Nasopharyngeal Carcinoma
- SIB-IMRT
- Cisplatin
-
Guangzhou, Guangdong, China
- +5 more
Jan 28, 2021
Cardiopulmonary Resuscitation Trial in Izmir (cardiopulmonary resuscitation)
Recruiting
- Cardiopulmonary Resuscitation
- cardiopulmonary resuscitation
-
İzmir, TurkeyIKCU, Atatürk Eğitim ve Araştırma Hastanesi, Acil Tıp
Sep 22, 2022
Biliary Tract Cancer Trial in Worldwide (Varlitinib, Capecitabine, Placebo (for Varlitinib))
Central Venous Catheter Placement Trial in Hamburg (Ultrasound-guided wire-in-needle technique for central venous catheter
Recruiting
- Central Venous Catheter Placement
- Ultrasound-guided wire-in-needle technique for central venous catheter placement
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Jul 6, 2022
Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)
Active, not recruiting
- Differentiated Thyroid Cancer
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Oct 18, 2021
Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer Trial in Kashiwa (Zolbetuximab)
Completed
- Gastric Cancer
- Gastro-esophageal Junction (GEJ) Cancer
-
Kashiwa, Chiba, JapanSite JP00001
Mar 3, 2021
Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chicago, Illinois
- +15 more
Oct 25, 2021
NSCLC Trial in Worldwide (PF-06747775, Palbociclib, Avelumab)
Terminated
- Non-Small Cell Lung Cancer
- PF-06747775
- +2 more
-
La Jolla, California
- +14 more
May 13, 2021
Rectal Cancer Trial in Netherlands (FOLFOXIRI Protocol)
Not yet recruiting
- Rectal Cancer
- FOLFOXIRI Protocol
-
Eindhoven, Noord-Brabant, Netherlands
- +6 more
Apr 6, 2021
Lung Squamous Cell Carcinoma, Neoadjuvant Therapy, Immunotherapy Trial in Hangzhou (Tislelizumab)
Recruiting
- Lung Squamous Cell Carcinoma
- +2 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of med
Aug 22, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)
Terminated
- Myelodysplastic Syndrome
- +2 more
- GVAX
- +6 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2022
Esophageal Cancer Trial in Groningen (Fluorescence endoscopy using durvalumab-680LT)
Not yet recruiting
- Esophageal Cancer
- Fluorescence endoscopy using durvalumab-680LT
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 4, 2022
HIV, Sinusitis Trial in United States (Pseudoephedrine HCl, Guaifenesin, Cefuroxime axetil)
Withdrawn
- HIV Infections
- Sinusitis
- Pseudoephedrine hydrochloride
- +3 more
-
San Diego, California
- +9 more
Oct 27, 2021
Smoldering Plasma Cell Myeloma Trial in United States (biological, drug, other)
Recruiting
- Smoldering Plasma Cell Myeloma
- Daratumumab
- +4 more
-
Anchorage, Alaska
- +595 more
Dec 7, 2022
NSCLC Trial (30 µg OBI-833/100 µg OBI-821, Erlotinib (150 mg daily))
Not yet recruiting
- Non-small Cell Lung Cancer
- 30 μg OBI-833/100 μg OBI-821
- Erlotinib (150 mg daily)
- (no location specified)
Jun 28, 2022